Impact of DOTA-Chelators on the Antitumor Activity of 177Lu-DOTA-Rituximab Preparations in Lymphoma Tumor-Bearing Mice.
暂无分享,去创建一个
R. Mikołajczak | P. Garnuszek | U. Karczmarczyk | A. Polyák | W. Wojdowska | Ewa Laszuk | A. Sawicka | Z. Pöstényi | Lajos Balog | Veronika Kovács-Haász